Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Sickle Cell Disease
Interventions
DRUG

sodium nitrite injection, usp

Sodium nitrite injection, USP will be administered in blocks of six subjects (3 sodium nitrite and 3 no drug). A total of five dose levels are planned, pending safety starting. Drug will be given by continuous infusion infusion for 48 hours starting at 6 nmol/min/kg (10% of the maximal tolerated dose).

Trial Locations (1)

90027

Childrens Hospital Los Angeles, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hope Pharmaceuticals

INDUSTRY

lead

Children's Hospital Los Angeles

OTHER